Sign inGet started

Magovcevic-Liebisch Ivana

Insider CIK 1279281 · AGTC Director · QTRX Director · AGLE Director · ABSI Director · ACRV Director · VIGL President and CEO, Director · DYAX EVP; Chief Operating Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
QTRX Quanterix Corp M Exercise deriv2026-10-022026-10-024,224— $04,352SEC↗
QTRX Quanterix Corp M Exercise2026-10-022026-10-024,224— —15,883SEC↗
ACRV Acrivon Therapeutics, Inc. A Award deriv2026-06-172026-06-2220,275— $020,275SEC↗
ACRV Acrivon Therapeutics, Inc. A Award2026-05-182026-05-209,366— $09,366SEC↗
QTRX Quanterix Corp A Award2026-01-022026-01-1523,372— $043,607SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2025-08-052025-08-05282,000— $00SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2025-08-052025-08-0543,271— $00SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2025-08-052025-08-05405,494— $00SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2025-08-052025-08-05210,629— $00SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2025-08-052025-08-05369,351— $00SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2025-08-052025-08-05485,000— $00SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2025-08-052025-08-05370,000— $00SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2025-08-052025-08-05463,000— $00SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer2025-08-052025-08-05222,687— $00SEC↗
ACRV Acrivon Therapeutics, Inc. A Award deriv2025-06-132025-06-1720,275— $020,275SEC↗
VIGL Vigil Neuroscience, Inc. A Award deriv2025-03-032025-03-04485,000— $0485,000SEC↗
QTRX Quanterix Corp A Award deriv2025-01-022025-01-0615,821— $015,821SEC↗
QTRX Quanterix Corp A Award2025-01-022025-01-067,435— $020,235SEC↗
VIGL Vigil Neuroscience, Inc. P Buy2024-12-192024-12-195,000$1.68 $8.4K222,687SEC↗
VIGL Vigil Neuroscience, Inc. P Buy2024-12-182024-12-185,000$1.67 $8.3K217,687SEC↗
VIGL Vigil Neuroscience, Inc. P Buy2024-12-052024-12-055,000$2.34 $11.7K212,687SEC↗
QTRX Quanterix Corp A Award deriv2024-10-022024-10-0327,689— $027,689SEC↗
QTRX Quanterix Corp A Award2024-10-022024-10-0312,800— $012,800SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2024-05-032024-05-07282,000— $00SEC↗
VIGL Vigil Neuroscience, Inc. A Award deriv2024-05-032024-05-07282,000— $0282,000SEC↗
VIGL Vigil Neuroscience, Inc. D To issuer deriv2024-05-032024-05-07370,000— $00SEC↗
VIGL Vigil Neuroscience, Inc. A Award deriv2024-05-032024-05-07370,000— $0370,000SEC↗
VIGL Vigil Neuroscience, Inc. A Award deriv2024-03-012024-03-01463,000— $0463,000SEC↗
ACRV Acrivon Therapeutics, Inc. A Award deriv2024-02-082024-02-0932,500— $032,500SEC↗
VIGL Vigil Neuroscience, Inc. P Buy2023-11-202023-11-204,000$3.75 $15.0K207,687SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2023-06-222023-06-301,950,000— $01,950,000SEC↗
VIGL Vigil Neuroscience, Inc. A Award deriv2023-03-012023-03-03370,000— $0370,000SEC↗
ABSI Absci Corp A Award deriv2022-06-082022-06-1028,700— $028,700SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2022-06-072022-06-0943,000— $043,000SEC↗
VIGL Vigil Neuroscience, Inc. P Buy2022-05-032022-05-041,000$3.94 $3.9K203,687SEC↗
VIGL Vigil Neuroscience, Inc. P Buy2022-05-022022-05-044,000$3.61 $14.4K202,687SEC↗
VIGL Vigil Neuroscience, Inc. A Award deriv2022-03-012022-03-03282,000— $0282,000SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2021-11-302021-12-0214,000— $014,000SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2021-06-082021-06-0940,000— $040,000SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2020-12-162020-12-1812,000— $012,000SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2020-06-082020-06-1028,100— $028,100SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2019-12-042019-12-0610,000— $010,000SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2019-06-072019-06-0712,400— $012,400SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2018-11-152018-11-1910,000— $010,000SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2018-07-252018-07-278,000— $08,000SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2018-07-252018-07-3010,000— $010,000SEC↗
AGLE Aeglea BioTherapeutics, In A Award deriv2018-03-222018-03-2636,800— $036,800SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2017-02-282017-03-028,000— $08,000SEC↗
AGTC APPLIED GENETIC TECHNOLOGI P Buy2016-11-162016-11-173,000$9.63 $28.9K3,000SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2015-11-192015-12-046,200— $06,200SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2014-12-192014-12-234,688— $04,688SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2014-07-112015-09-289,375— $09,375SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-29126,666— $0126,666SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-2915,624— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-2915,624— $015,624SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-2949,999— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-2949,999— $049,999SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-2912,499— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-2912,499— $012,499SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-2937,499— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-2937,499— $037,499SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-29141,183— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-29141,183— $0141,183SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-29150,000— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-29150,000— $0150,000SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-29190,000— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-29190,000— $0190,000SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-29145,000— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-29145,000— $0145,000SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-29100,000— $00SEC↗
DYAX DYAX CORP A Award deriv2013-03-292013-03-29100,000— $0100,000SEC↗
DYAX DYAX CORP D To issuer deriv2013-03-292013-03-29126,666— $00SEC↗
DYAX DYAX CORP M Exercise deriv2013-03-062013-03-08128,125— $021,875SEC↗
DYAX DYAX CORP M Exercise deriv2013-03-062013-03-0812,083— $0132,917SEC↗
DYAX DYAX CORP M Exercise deriv2013-03-062013-03-0867,291— $0122,709SEC↗
DYAX DYAX CORP M Exercise2013-03-062013-03-0812,083$1.48 $17.9K255,984SEC↗
DYAX DYAX CORP S Sale2013-03-062013-03-08204,478$4.00 $817.9K51,506SEC↗
DYAX DYAX CORP S Sale2013-03-062013-03-083,021$4.01 $12.1K48,485SEC↗
DYAX DYAX CORP S Sale2013-03-062013-03-087,860$4.00 $31.4K40,625SEC↗
DYAX DYAX CORP M Exercise2013-03-062013-03-0867,291$1.91 $128.5K243,901SEC↗
DYAX DYAX CORP M Exercise2013-03-062013-03-08128,125$2.39 $306.2K176,610SEC↗
DYAX DYAX CORP S Sale2013-02-252013-02-274,015$3.24 $13.0K48,485SEC↗
DYAX DYAX CORP A Award deriv2013-02-072013-02-11235,000— $0235,000SEC↗
DYAX DYAX CORP A Award deriv2012-10-102012-10-12100,000— $0100,000SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2280,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2215,624— $015,624SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2225,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-22126,666— $0126,666SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-22190,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2212,187— $012,187SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2218,281— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2215,999— $015,999SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2240,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2249,999— $049,999SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2220,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2212,499— $012,499SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2260,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2237,499— $037,499SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2250,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2219,999— $019,999SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2260,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2240,000— $040,000SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2212,500— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-225,000— $05,000SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2260,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2223,999— $023,999SEC↗
DYAX DYAX CORP D To issuer deriv2012-06-202012-06-2260,000— $00SEC↗
DYAX DYAX CORP A Award deriv2012-06-202012-06-2223,999— $023,999SEC↗
DYAX DYAX CORP A Award deriv2012-02-242012-02-28145,000— $0145,000SEC↗
DYAX DYAX CORP A Award2012-02-242012-02-2847,500— $052,500SEC↗